(Q44503536)

English

Use of the peroxisome proliferator-activated receptor (PPAR) gamma ligand troglitazone as treatment for refractory breast cancer: a phase II study

scientific article published in June 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Use of the peroxisome proliferator-activated receptor (PPAR) gamma ligand troglitazone as treatment for refractory breast cancer: a phase II study (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Bruce Spiegelman

5

object named as

Bruce M Spiegelman

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Harold J. Burstein

1

object named as

Harold J Burstein

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

6

object named as

Eric P Winer

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

George D Demetri

2

object named as

George D Demetri

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

author name string

Elisabetta Mueller

3

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Pasha Sarraf

4

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

language of work or name

0 references

publication date

1 June 2003

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Breast Cancer Research and Treatment

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

79

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

391-397

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Nonhypoglycemic effects of thiazolidinediones

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1024038127156

21 January 2018

Roles of PPARs in health and disease.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1024038127156

7 January 2021

based on heuristic

inferred from DOI database lookup

The mechanisms of action of PPARs

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1024038127156

7 January 2021

based on heuristic

inferred from DOI database lookup

PPAR-gamma: adipogenic regulator and thiazolidinedione receptor

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1024038127156

7 January 2021

based on heuristic

inferred from DOI database lookup

The structure-activity relationship between peroxisome proliferator-activated receptor gamma agonism and the antihyperglycemic activity of thiazolidinediones

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1024038127156

7 January 2021

based on heuristic

inferred from DOI database lookup

Adipogenesis and obesity: rounding out the big picture

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1024038127156

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction of solid tumor differentiation by the peroxisome proliferator-activated receptor-gamma ligand troglitazone in patients with liposarcoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1024038127156

7 January 2021

based on heuristic

inferred from DOI database lookup

PPARgamma and colorectal carcinoma: conflicts in a nuclear family

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1024038127156

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of ligand activation of peroxisome proliferator-activated receptor gamma in human prostate cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1024038127156

7 January 2021

based on heuristic

inferred from DOI database lookup

Terminal differentiation of human breast cancer through PPAR gamma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1024038127156

7 January 2021

based on heuristic

inferred from DOI database lookup

Troglitazone inhibits growth of MCF-7 breast carcinoma cells by targeting G1 cell cycle regulators

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1024038127156

7 January 2021

based on heuristic

inferred from DOI database lookup

Ligands for peroxisome proliferator-activated receptorgamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1024038127156

7 January 2021

based on heuristic

inferred from DOI database lookup

A ligand of peroxisome proliferator-activated receptor gamma, retinoids, and prevention of preneoplastic mammary lesions

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1024038127156

7 January 2021

based on heuristic

inferred from DOI database lookup

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1024038127156

7 January 2021

based on heuristic

inferred from DOI database lookup

Lessons from the glitazones: a story of drug development

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1024038127156

7 January 2021

based on heuristic

inferred from DOI database lookup

APC-dependent suppression of colon carcinogenesis by PPARgamma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1024038127156

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1023/A:1024038127156

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44503536&oldid=2206694046"